Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples

被引:46
|
作者
Yoshikawa, T
Kikuchi, M
Saito, K
Watanabe, A
Yamada, K
Shibuya, H
Nankai, M
Kurumaji, A
Hattori, E
Ishiguro, H
Shimizu, H
Okubo, Y
Toru, M
Detera-Wadleigh, SD
机构
[1] RIKEN, Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan
[2] Tokyo Med & Dent Univ, Dept Neuropsychiat, Tokyo, Japan
[3] Tokyo Metropolitan Police Hosp, Dept Neuropsychiat, Tokyo, Japan
[4] Hokushin Gen Hosp, Nagano, Japan
[5] NIMH, Intramural Program, NIH, Bethesda, MD 20892 USA
关键词
chromosome; 18; affective disorder; polymorphism; linkage disequilibrium; haplotype; LightCycler;
D O I
10.1038/sj.mp.4000835
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In our search for candidate genes for affective disorder on the short arm of chromosome 18, we cloned IMPA2, a previously unreported myo-inositol monophosphatase gene, that maps to 18p11.2. We determined its genomic structure and detected three new single nucleotide polymorphisms (SNPs). In the present study, we screened the gene further to search for additional polymorphisms in Japanese samples and identified seven other SNPs, including a novel missense mutation. These polymorphisms clustered into three regions of the gene. Three relatively informative SNPs, 58G>A, IVS1-15G>A and 800C>T from clusters 1, 2 and 3, respectively, were selected for association tests using a case-control design. The Japanese cohort included 302 schizophrenics, 205 patients with affective disorder and 308 controls. Genotyping was done either by melting curve analysis on the LightCycler or by sequencing. All three SNPs showed significant genotypic association (nominal P = 0.031-0.0001) with schizophrenia, but not with affective disorder. These findings increase the relevance of 18p11.2 to schizophrenia susceptibility because GNAL, which has been shown previously to be implicated in schizophrenia in an independent study, is in close physical proximity to IMPA2. Our findings suggest that IMPA2 or a gene nearby may contribute to the overall genetic risk for schizophrenia among Japanese.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 50 条
  • [1] Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples
    T Yoshikawa
    M Kikuchi
    K Saito
    A Watanabe
    K Yamada
    H Shibuya
    M Nankai
    A Kurumaji
    E Hattori
    H Ishiguro
    H Shimizu
    Y Okubo
    M Toru
    S D Detera-Wadleigh
    Molecular Psychiatry, 2001, 6 : 202 - 210
  • [2] Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples.
    Kikuchi, M
    Saito, K
    Watanabe, A
    Yamada, K
    Shibuya, M
    Nankai, M
    Kurumaji, A
    Hattori, E
    Ishiguro, H
    Shimizu, H
    Okubo, Y
    Toru, M
    Detera-Wadleigh, SD
    Yoshikawa, T
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 96 (04): : 477 - 477
  • [3] Association analysis between polymorphisms in the myo-inositol monophosphatase 2 (IMPA2) gene and bipolar disorder
    Bloch, Paul J.
    Weller, Andrew E.
    Doyle, Glenn A.
    Ferraro, Thomas N.
    Berrettini, Wade H.
    Hodge, Rachel
    Lohoff, Falk W.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (08): : 1515 - 1519
  • [4] Behavioural characterization of Myo-inositol monophosphatase (IMPA2)-deficient mice
    Balemans, W
    Moechars, D
    Kass, S
    Goris, I
    Daneels, G
    Van Craenendonck, H
    Steckler, T
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S71 - S71
  • [5] Lack of association of myo-inositol monophosphatase 2 (IMPA2) polymophisms and bipolar affective disorder
    Dimitrova, AZ
    Nikolov, I
    Kostov, C
    Toncheva, D
    Owen, MJ
    Kirov, G
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 78 - 79
  • [6] Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2)
    T Yoshikawa
    M Padigaru
    J D Karkera
    M Sharma
    W H Berrettini
    L E Esterling
    S D Detera-Wadleigh
    Molecular Psychiatry, 2000, 5 : 165 - 171
  • [7] Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2)
    Yoshikawa, T
    Padigaru, M
    Karkera, JD
    Sharma, M
    Berrettini, WH
    Esterling, LE
    Detera-Wadleigh, SD
    MOLECULAR PSYCHIATRY, 2000, 5 (02) : 165 - 171
  • [8] Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder
    Tomioka, Yoko
    Jimenez, Esther
    Salagre, Estela
    Arias, Barbara
    Mitjans, Marina
    Ruiz, Victoria
    Saiz, Pilar
    Paz Garcia-Portilla, Maria
    de la Fuente, Lorena
    Patricia Gomes-da-Costa, Susana
    Bobes, Julio
    Vieta, Eduard
    Benabarre, Antoni
    Grande, Iria
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 232 : 229 - 236
  • [9] Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment
    A Dimitrova
    V Milanova
    S Krastev
    I Nikolov
    D Toncheva
    M J Owen
    G Kirov
    The Pharmacogenomics Journal, 2005, 5 : 35 - 41
  • [10] Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment
    Dimitrova, A
    Milanova, V
    Krastev, S
    Nikolov, I
    Toncheva, D
    Owen, MJ
    Kirov, G
    PHARMACOGENOMICS JOURNAL, 2005, 5 (01): : 35 - 41